Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in J Gastroenterol

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    April 2024
  1. MAKUUCHI M, Kakuta Y, Umeno J, Fujii T, et al
    Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study.
    J Gastroenterol. 2024 Apr 8. doi: 10.1007/s00535-024-02099.
    PubMed     Abstract available


    March 2024
  2. HIRAYAMA D, Hyodo S, Morita K, Nakase H, et al
    Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis.
    J Gastroenterol. 2024 Mar 16. doi: 10.1007/s00535-024-02086.
    PubMed     Abstract available


    January 2024
  3. NAGANUMA M, Nakamura N, Kunisaki R, Matsuoka K, et al
    Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria.
    J Gastroenterol. 2024 Jan 26. doi: 10.1007/s00535-024-02079.
    PubMed     Abstract available


  4. KOMATSU H, Morikubo H, Kimura Y, Moue C, et al
    A combination of bowel wall thickness and submucosa index is useful for estimating endoscopic improvement in ulcerative colitis: external validation of the Kyorin Ultrasound Criterion.
    J Gastroenterol. 2024 Jan 21. doi: 10.1007/s00535-024-02077.
    PubMed     Abstract available


    November 2023
  5. YOKOTE A, Imazu N, Umeno J, Kawasaki K, et al
    Reply to "Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis".
    J Gastroenterol. 2023 Nov 27. doi: 10.1007/s00535-023-02064.
    PubMed    


  6. SUN S, Lv B
    The antiferroptotic effect of indigo on ulcerative colitis.
    J Gastroenterol. 2023 Nov 23. doi: 10.1007/s00535-023-02063.
    PubMed     Abstract available


    October 2023
  7. NAGANUMA M, Kobayashi T, Kunisaki R, Matsuoka K, et al
    Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis.
    J Gastroenterol. 2023 Oct 13. doi: 10.1007/s00535-023-02048.
    PubMed     Abstract available


    August 2023
  8. WATANABE K, Nojima M, Nakase H, Sato T, et al
    Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT.
    J Gastroenterol. 2023 Aug 10. doi: 10.1007/s00535-023-02029.
    PubMed     Abstract available


    July 2023
  9. PARKES G, Ungaro RC, Danese S, Abreu MT, et al
    Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis.
    J Gastroenterol. 2023 Jul 25. doi: 10.1007/s00535-023-02013.
    PubMed     Abstract available


  10. SAKURAI T, Omori T, Tanaka H, Ito T, et al
    Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn's disease in Japan (SPREAD-J study).
    J Gastroenterol. 2023 Jul 21. doi: 10.1007/s00535-023-02017.
    PubMed     Abstract available


  11. YOKOTE A, Imazu N, Umeno J, Kawasaki K, et al
    Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis.
    J Gastroenterol. 2023 Jul 6. doi: 10.1007/s00535-023-02016.
    PubMed     Abstract available


    June 2023
  12. MATSUOKA K, Yamazaki H, Nagahori M, Kobayashi T, et al
    Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.
    J Gastroenterol. 2023 Jun 23. doi: 10.1007/s00535-023-02005.
    PubMed     Abstract available


  13. YOSHIDA H, Shiokawa M, Kuwada T, Muramoto Y, et al
    Anti-integrin alphavbeta6 autoantibodies in patients with primary sclerosing cholangitis.
    J Gastroenterol. 2023 Jun 13. doi: 10.1007/s00535-023-02006.
    PubMed     Abstract available


  14. SHINZAKI S, Sato T, Fukui H
    Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammation.
    J Gastroenterol. 2023;58:598-599.
    PubMed    


    May 2023
  15. MATSUOKA K, Fujii T, Okamoto R, Yamada A, et al
    Correction: Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD).
    J Gastroenterol. 2023 May 5. doi: 10.1007/s00535-023-01998.
    PubMed    


    April 2023
  16. WATANABE S, Ogasawara N, Kobayashi S, Kirino S, et al
    Organoids transplantation as a new modality to design epithelial signature to create a membrane-protective sulfomucin-enriched segment.
    J Gastroenterol. 2023;58:379-393.
    PubMed     Abstract available


    March 2023
  17. YAMAKAWA T, Kitamoto H, Nojima M, Kazama T, et al
    Correction: The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection.
    J Gastroenterol. 2023 Mar 8. doi: 10.1007/s00535-023-01979.
    PubMed    


  18. NAMBU R, Arai K, Kudo T, Murakoshi T, et al
    Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort study.
    J Gastroenterol. 2023 Mar 8. doi: 10.1007/s00535-023-01972.
    PubMed     Abstract available


    February 2023
  19. NAKASE H, Esaki M, Hirai F, Kobayashi T, et al
    Treatment escalation and de-escalation decisions in Crohn's disease: Delphi consensus recommendations from Japan, 2021.
    J Gastroenterol. 2023 Feb 11. doi: 10.1007/s00535-023-01958.
    PubMed     Abstract available


  20. ISHIGE T, Shimizu T, Watanabe K, Arai K, et al
    Correction to: Expert consensus on vaccination in patients with inflammatory bowel disease in Japan.
    J Gastroenterol. 2023 Feb 10. doi: 10.1007/s00535-023-01965.
    PubMed    


    January 2023
  21. ISHIGE T, Shimizu T, Watanabe K, Arai K, et al
    Expert consensus on vaccination in patients with inflammatory bowel disease in Japan.
    J Gastroenterol. 2023 Jan 11. doi: 10.1007/s00535-022-01953.
    PubMed     Abstract available


  22. NAKASE H, Wagatsuma K, Nojima M, Matsumoto T, et al
    Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
    J Gastroenterol. 2023 Jan 6. doi: 10.1007/s00535-022-01949.
    PubMed     Abstract available


    November 2022
  23. ANDOH A, Nishida A
    Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease.
    J Gastroenterol. 2022 Nov 14. pii: 10.1007/s00535-022-01936.
    PubMed     Abstract available


  24. MATSUOKA K, Fujii T, Okamoto R, Yamada A, et al
    Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD).
    J Gastroenterol. 2022;57:867-878.
    PubMed     Abstract available


    October 2022
  25. YAMAWAKA T, Kitamoto H, Nojima M, Kazama T, et al
    The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection.
    J Gastroenterol. 2022 Oct 26. pii: 10.1007/s00535-022-01931.
    PubMed     Abstract available


  26. OHARA J, Nemoto T, Maeda Y, Ogata N, et al
    Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission.
    J Gastroenterol. 2022 Oct 3. pii: 10.1007/s00535-022-01924.
    PubMed     Abstract available


  27. NOGUCHI T, Ishihara S, Uchino M, Ikeuchi H, et al
    Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn's disease.
    J Gastroenterol. 2022 Oct 2. pii: 10.1007/s00535-022-01927.
    PubMed     Abstract available


  28. WANG Z, Iida N, Seishima J, Okafuji H, et al
    Patient-derived Enterococcus faecium with inflammatory genotypes promote colitis.
    J Gastroenterol. 2022;57:770-783.
    PubMed     Abstract available


    August 2022
  29. IMAI T, Inoue R, Nishida A, Yokota Y, et al
    Features of the gut prokaryotic virome of Japanese patients with Crohn's disease.
    J Gastroenterol. 2022;57:559-570.
    PubMed     Abstract available


    July 2022
  30. JORDI SBU, Lang BM, Wyss J, Auschra B, et al
    The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients.
    J Gastroenterol. 2022 Jul 28. pii: 10.1007/s00535-022-01902.
    PubMed     Abstract available


  31. VAN HOEVE K, Hoffman I
    Renal manifestations in inflammatory bowel disease: a systematic review.
    J Gastroenterol. 2022 Jul 14. pii: 10.1007/s00535-022-01903.
    PubMed     Abstract available


  32. ALLIN KH, Jensen CB, Jacobsen RK, Jess T, et al
    Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study.
    J Gastroenterol. 2022 Jul 2. pii: 10.1007/s00535-022-01896.
    PubMed     Abstract available


    March 2022
  33. KISHI M, Hirai F, Takatsu N, Hisabe T, et al
    A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation.
    J Gastroenterol. 2022 Mar 2. pii: 10.1007/s00535-022-01862.
    PubMed     Abstract available


    February 2022
  34. SHIMIZU H, Ebana R, Kudo T, Sato T, et al
    Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease.
    J Gastroenterol. 2022 Feb 14. pii: 10.1007/s00535-022-01856.
    PubMed     Abstract available


    January 2022
  35. NAKASE H, Hayashi Y, Hirayama D, Matsumoto T, et al
    Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS).
    J Gastroenterol. 2022 Jan 28. pii: 10.1007/s00535-022-01851.
    PubMed     Abstract available


  36. MIYOSHI J, Ozaki R, Yonezawa H, Mori H, et al
    Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis.
    J Gastroenterol. 2022 Jan 24. pii: 10.1007/s00535-021-01847.
    PubMed     Abstract available


    October 2021
  37. ANDO K, Fujiya M, Watanabe K, Hiraoka S, et al
    A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan.
    J Gastroenterol. 2021 Oct 5. pii: 10.1007/s00535-021-01829.
    PubMed     Abstract available


    September 2021
  38. MIURA M, Shimizu H, Saito D, Miyoshi J, et al
    Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study).
    J Gastroenterol. 2021 Sep 30. pii: 10.1007/s00535-021-01832.
    PubMed     Abstract available


  39. TOYONAGA T, Kobayashi T, Kuronuma S, Ueno A, et al
    Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation.
    J Gastroenterol. 2021 Sep 4. pii: 10.1007/s00535-021-01820.
    PubMed     Abstract available


    August 2021
  40. NISHIOKA K, Ogino H, Chinen T, Ihara E, et al
    Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease.
    J Gastroenterol. 2021 Aug 27. pii: 10.1007/s00535-021-01819.
    PubMed     Abstract available


    July 2021
  41. MATSUOKA K, Ishikawa H, Nakayama T, Honzawa Y, et al
    Physician-patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis.
    J Gastroenterol. 2021 Jul 27. pii: 10.1007/s00535-021-01811.
    PubMed     Abstract available


  42. ANDOH A, Kawahara M, Imai T, Tatsumi G, et al
    Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease.
    J Gastroenterol. 2021 Jul 21. pii: 10.1007/s00535-021-01805.
    PubMed     Abstract available


    May 2021
  43. SHINZAKI S, Matsuoka K, Tanaka H, Takeshima F, et al
    Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.
    J Gastroenterol. 2021 May 3. pii: 10.1007/s00535-021-01793.
    PubMed     Abstract available


    April 2021
  44. NAKASE H, Uchino M, Shinzaki S, Matsuura M, et al
    Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.
    J Gastroenterol. 2021 Apr 22. pii: 10.1007/s00535-021-01784.
    PubMed     Abstract available


    January 2021
  45. TAKABAYASHI K, Hosoe N, Kato M, Hayashi Y, et al
    Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn's disease in clinical remission.
    J Gastroenterol. 2021;56:25-33.
    PubMed     Abstract available


    November 2020
  46. KOHYAMA A, Watanabe K, Sugita A, Futami K, et al
    Ulcerative colitis-related severe enteritis: an infrequent but serious complication after colectomy.
    J Gastroenterol. 2020 Nov 5. pii: 10.1007/s00535-020-01742.
    PubMed     Abstract available


  47. KITA T, Ashizuka S, Ohmiya N, Yamamoto T, et al
    Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial.
    J Gastroenterol. 2020 Nov 2. pii: 10.1007/s00535-020-01741.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.